Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-κB inhibition via HGF

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 757-766

  Bendinelli, Paola ^a   Matteucci, Emanuela ^a   Dogliotti, Giada ^a   Corsi, Massimiliano M ^a,b   Banfi, Giuseppe ^a,b   Maroni, Paola ^b   Desiderio, Maria Alfonsina ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN P50; SCATTER FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; AUTACOID; CXCR4 PROTEIN, HUMAN; HGF PROTEIN, HUMAN; I KAPPA B; IL4 PROTEIN, HUMAN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NFKB1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; RELA PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE INJURY; CHEMOTAXIS; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; GENE EXPRESSION; GENE TARGETING; HEALING; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; NUCLEOLUS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REGENERATION; THROMBOCYTE RICH PLASMA; TRANSACTIVATION; ACTIVE TRANSPORT; BLOOD; CELL STRAIN U937; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; THROMBOCYTE; THROMBOCYTE TRANSFUSION; TRANSCRIPTION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; BLOOD PLATELETS; CHEMOKINE CXCL12; CHEMOTAXIS; CHONDROCYTES; CYCLOOXYGENASE 2; HEPATOCYTE GROWTH FACTOR; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-4; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PHOSPHORYLATION; PLATELET TRANSFUSION; RECEPTORS, CXCR4; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 77957731017     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22274     Document Type: Article

References (56)

1. Alaaeddine N, Di Battista JA, Pelletier JP, Kiansa K, Cloutier JM, Martel-Pelletier J. 1999. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the anti-inflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: Distinct targeting in the signalling pathways. Arthritis Rheum 42: 710-718.
2. Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, Dargemont C. 1997. Nuclear localization of I kappa B alpha promotes active transport of NF-kB from the nucleus to the cytoplasm. J Cell Sci 110: 369-378.
3. Banfi G, Corsi MM, Volpi P. 2006. Could platelet rich plasma have effects on systemic circulating growth factors and cytokine release in orthopedic applications? Br J Sports Med 40: 816.
4. Bendinelli P, Matteucci E, Maroni P, Desiderio MA. 2009. NF-kB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells. Mol Cancer Res 7: 1328-1341.
5. Brehm W, Aklin B, Yamashita T, Reiser F, Trüb T, Jakob RP, Mainil-Varlet P. 2006. Repair of superficial osteochondral defects with an autologous scaffold-free cartilage construct in a caprine model: Implantation method and short-term results. Osteoarthritis Cartilage 14: 1214-1226.
6. Cervelli V, Palla L, Pascali M, De Angelis B, Curcio BC, Gentile P. 2009. Autologous platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery. Aesthetic Plast Surg 33: 716-721.
7. Chen J, Zhao M, Rao R, Inoue H, Hao C-M. 2005. C/EBPΒ and its binding element are required for NFkB-induced COX2 expression following hypertonic stress. J Biol Chem 280: 16354-16359.
8. Desiderio MA. 2007. Hepatocyte growth factor in invasive growth of carcinomas. Cell Mol Life Sci 64: 1341-1354.
9. Desiderio MA, Pogliaghi G, Dansi P. 1998. Hepatocyte growth factor-induced expression of ornithine decarboxylase, c-met, and c-myc is differently affected by protein kinase inhibitors in human hepatoma cells HepG2. Exp Cell Res 242: 401-409.
10. El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dayke TE. 2007. Platelet-rich plasma: Growth factors and pro-and anti-inflammatory properties. J Periodontol 78: 661-669.
11. Gao Z, Chiao P, Zhang X, Lazar MA, Seto E, Young HA, Ye J. 2005. Coactivators and corepressors of NF-kB in IkBα gene promoter. J Biol Chem 280: 21091-21098.
12. Ghosh S, Hayden MS. 2008. New regulators of NF-kB in inflammation. Nat Rev Immunol 8: 837-848.
13. Giannopoulou M, Dai C, Tan X, Wen X, Michalopoulos GK, Liu Y. 2008. Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kB signalling. Am J Pathol 173: 30-41.
14. Gong R. 2008. Multi-target anti-inflammatory action of hepatocyte growth factor. Curr Opin Invest Drugs 9: 1163-1170.
15. Gong R, Rifai A, Dworkin LD. 2006. Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: Targeting the inflamed vascular endothelium. J Am Soc Nephrol 17: 2464-2473.
16. Grigolo B, Roseti L, Neri S, Gobbi P, Jensen P, Major EO, Facchini A. 2002. Human articular chondrocytes immortalized by HPV-16 E6 and E7 genes: Maintenance of differentiated phenotype under defined culture conditions. Osteoarthritis Cartilage 10: 879-889.
17. Han KY, Kim CW, Lee TH, Son Y, Kim J. 2009. CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells. Biochem Biophys Res Commun 382: 124-128.
18. Hanna R, Trejo PM, Weltman RL. 2004. Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: A randomized clinical trial. J Periodontol 75: 1668-1677.
19. Haringman JJ, Ludikhuize J, Tak PP. 2004. Chemokines in joint disease: The key to inflammation? Ann Rheum Dis 63: 1186-1194.
20. Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T. 2006. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-Β enhances bone metastases in breast cancer. Cancer Res 66: 2067-2073.
21. Hochrainer K, Racchumi G, Anrather J. 2007. Hypo-phosphorylation leads to nuclear retention of NF-kB p65 due to impaired IκBα gene synthesis. FEBS Lett 581: 5493-5499.
22. Ito CY, Kazantsev AG, Baldwin AS, Jr. 1994. Three NF-kB sites in the IkBα promoter are required for induction of gene expression by TNFα. Nucleic Acid Res 22: 3787-3792.
23. Iwai K, Lee BR, Hashiguchi M, Fukushima A, Iwashima M. 2005. IkB-α-specific transcript regulation by the C-terminal end of c-Rel. FEBS Lett 579: 141-144.
24. Julkunen I, Melén K, Nyqvist M, Pirhonen J, Sareneva T, Matikainen S. 2001. Inflammatory responses in influenza A virus infection. Vaccine 19: S32-S37.
25. Kim S, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH. 2009. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK/STAT-3 pathway in a SKBR3 breast cancer cell line. Cell Signal 21: 892-898.
26. Kishi Y, Kuba K, Nakamura T, Wen J, Suzuki Y, Mizuno S, Nukiwa T, Matsumoto K, Nakamura T. 2009. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngenic mouse tumor models. Cancer Sci 100: 1351-1358.
27. Koyama T, Hora K, Ako S, Kamijo Y, Higuchi M. 2003. Expression of hepatocyte growth factor is induced by the interaction between human mesangial cells and monocytes. Nephron Exp Nephrol 94: e146-e153.
28. Lacoste E, Martineau I, Gagnon G. 2003. Platelet concentrates: Effects of calcium and thrombin on endothelial cell proliferation and growth factor release. J Periodontol 74: 1498-1507.
29. Lee YH, Suzuki YJ, Griffin AJ, Day RM. 2008. Hepatocyte growth factor regulates cyclooxygenase-2 expression via Β-catenin, Akt, and p42/44 MAPK in human bronchial epithelial cells. Am J Physiol 294: L778-L786.
30. Legitimo A, Consolini R, Failli A, Fabiano S, Bencivelli W, Scatena F, Mosca F. 2007. In vitro treatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype. Clin Exp Immunol 148: 564-572.
31. Li H, Lin X. 2008. Positive and negative signaling components involved in TNFα-induced NF-kB activation. Cytokine 41: 1-8.
32. Maroni P, Bendinelli P, Matteucci E, Desiderio MA. 2007. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kB. Carcinogenesis 28: 267-279.
33. Moriuchi H, Moriuchi M, Arthos J, Hoxie J, Fauci AS. 1997. Promonocytic U937 subclone expressing CD4 and CXCR4 are resistant to infection and cell to cell fusion by T-cell-tropic human immunodeficiency virus type 1. J Virol 71: 9664-9671.
34. Nam NH. 2006. Naturally occurring NF-kB inhibitors. Mini Rev Med Chem 6: 945-951.
35. Oberyszyn TM. 2007. Inflammation and wound healing. Front Biosci 12: 2993-2999.
36. Pallua N, Wolter T, Markowicz M. 2010. Platelet rich plasma in burns. Burns 36: 4-8.
37. Pazdrak K, Olszewska-Pazdrak B, Liu T, Takizawa R, Brasier AR, Garofalo RP, Casola A. 2002. MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 283: L364-L372.
38. Perkins ND. 2006. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25: 6717-6730.
39. Pillitteri D, Bassus S, Boller K, Mahnel R, Scholz T, Westrup D, Wegert W, Kirchmaier CM. 2007. Thrombin-induced interleukin 1beta synthesis in platelet suspensions: Impact of contaminating leukocytes. Platelets 18: 119-127.
40. Psarra AM, Hermann S, Panayotou G, Spyrou G. 2009. Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kB modulates glucocorticoid receptor and NF-kB signalling in HEK-293 cells. Biochem J 422: 521-531.
41. Puri RN. 1998. Phospholipase A2: Its role in ADP- and thrombin-induced platelet activation mechanisms. Int J Biochem Cell Biol 30: 1107-1122.
42. Roseti L, Facchini A, De Franceschi L, Marconi E, Major EO, Grigolo B. 2007. Induction of original phenotype of human immortalized chondrocytes: A quantitative gene expression analysis. Int J Mol Med 19: 89-96.
43. Roussy Y, Duchesne MPB, Gagnon G. 2007. Activation of human platelet-rich plasma: Effect on growth factor release, cell division and in vivo bone formation. Clin Oral Impl Res 18: 639-648.
44. Sampson S, Gerhardt M, Mandelbaum B. 2008. Platelet rich plasma injection grafts for musculoskeletal injuries: A review. Curr Rev Musculoskelet Med 1: 165-174.
45. Schmitz ML, Baeuerle PA. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-kB. EMBO J 10: 3805-3817.
46. Seruga B, Zhang H, Bernstein LJ, Tannock IF. 2008. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8: 887-899.
47. Stadnicki A, Mechnik G, Klimacka-Nawrot E, Wolanska-Karut A, Labuzek K. 2009. Transforming growth factor-Β1 and its receptors in patients with ulcerative colitis. Int Immunopharmacol 9: 761-766.
48. Tischler M. 2002. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts. NY State Dent J 68: 22-24.
49. Toyama T, Ido A, Sasak H, Maeda K, Yamashita K, Kubiki Y, Suzuki M, Matsuoka H, Tsubouchi H. 2005. Possible involvement of neutrophils in a serum level increase of hepatocyte growth factor in non-Hodgkin's lymphoma. Oncol Rep 13: 439-444.
50. Ulivi V, Giannoni P, Gentili C, Cancedda R, Descalzi F. 2008. p38/NF-kB-dependent expression of COX-2 during differentiation and inflammatory response of chondrocytes. J Cell Biochem 104: 1393-1406.
51. Vardar-Sengul S, Arora S, Baylas H, Mercola D. 2009. Expression profile of human gingival fibroblasts induced by interleukin-1Β reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation. J Periodontol 80: 833-849.
52. Wang W, Huang XR, Li AG, Liu F, Li J-H, Truong LD, Wang XJ, Lan HY. 2005. Signaling mechanism of TGF-Β1 in prevention of renal inflammation: Role of Smad 7. J Am Soc Nephrol 16: 1371-1383.
53. Wu W, Zhang J, Dong Q, Liu Y, Mao T, Chen F. 2009. Platelet-rich plasma-A promising cell carrier for micro-invasive articular cartilage repair. Med Hyp 72: 455-457.
54. Yue L, Christman JW, Mazzone T. 2008. Tumor necrosis factor-α-mediated suppression of adipocytes apolipoprotein E gene transcription: Primary role for the nuclear factor (NF)-kB pathway and NF-kB p50. Endocrinology 149: 4051-4058.
55. Zabel BA, Wang Y, Lewén S, Berahovich RD, Penfold MET, Zhang P, Powers J, Summers BC, Miao Z, Zhao B, Jalili A, Janowska-Wieczorek A, Jaen JC, Schall TJ. 2009. Elucidation of CXCR7-mediating signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 183: 3204-3211.
56. Zetoune FS, Murthy AR, Shao Z, Haling T, Zeildler MG, Li Y, Vincenz C. 2001. A20 inhibits NF-kB activation downstream of multiple MAP3 kinases and interacts with IkB signalosome. Cytokine 15: 282-298.